We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Marker Panel Detects Early Liver Cancer with Increased Sensitivity

By LabMedica International staff writers
Posted on 05 Dec 2019
Print article
Image: Photomicrograph of histology of fibrolamellar hepatocellular carcinoma, showing large polygonal tumors cells with granular eosinophilic cytoplasm (Photo courtesy of Nephron)
Image: Photomicrograph of histology of fibrolamellar hepatocellular carcinoma, showing large polygonal tumors cells with granular eosinophilic cytoplasm (Photo courtesy of Nephron)
Several types of cancer can form in the liver. The most common type of liver cancer is hepatocellular carcinoma, which begins in the main type of liver cell (hepatocyte). Other types of liver cancer, such as intrahepatic cholangiocarcinoma and hepatoblastoma, are much less common.

Tests and procedures used to diagnose liver cancer include blood tests that may reveal liver function abnormalities; Imaging test, such as an ultrasound, computerized tomography (CT) and magnetic resonance imaging (MRI) or a biopsy by removing a sample of liver tissue for testing.

Scientists from the Mayo Clinic (Rochester, MN, USA) collaborating with the commercial company Exact Sciences (Madison, WI, USA) collected blood samples from 137 radiographically diagnosed hepatocellular carcinoma (HCC) and 313 age-matched controls with benign liver disease without structurally apparent HCC. They assessed 10 methylated markers that had previously been reported as having some association with HCC, as well as several protein markers including alpha-fetoprotein (AFP).

The investigators found that the panel had a specificity of 90%, and they reported that their panel of six markers detected early-stage HCC with a sensitivity of 71% compared to 25% for AFP. The panel also detected Stage A HCC with a sensitivity of 74% compared to 30% for AFP. Overall, the panel's sensitivity was 82.6% compared to 47.1% for AFP. At 90% specificity, AFP's sensitivity was 45%. The team chose to include AFP and an AFP isoform called AFP-L3 as the two protein markers in the panel. AFP-L3 is represented as a ratio of a lectin protein to total AFP: the AFP-L3% assay is used to help identify people at risk of developing HCC, and studies have shown that AFP-L3% test results higher than 10% can be indicative of early HCC. They further found that the addition of methylation markers gave the test more diagnostic power than the addition of DNA mutation markers would have.

John B. Kisiel, MD, an associate professor of gastroenterology and hepatology, and a co-author of the study, said, “We think that the data are a very compelling indication that this new panel of markers is substantially better than AFP. The difficulty with ultrasound is that while it's the current standard of care, it is also often insensitive for early-stage cancers, and although it's relatively widely available, it depends on a human operator to take the pictures, and it depends on patients coming in to have it done.” The study was presented at the Annual meeting for the American Association for the Study of Liver Diseases, held November 13-17, 2019 in Boston, MA, USA).

Related Links:
Mayo Clinic
Exact Sciences


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.